These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17296405)

  • 1. Phase I/II examination of transurethral ethanol ablation of the prostate for the treatment of symptomatic benign prostatic hyperplasia.
    Plante MK; Marks LS; Anderson R; Amling C; Rukstalis D; Badlani G; Getlin L; Vang E
    J Urol; 2007 Mar; 177(3):1030-5; discussion 1035. PubMed ID: 17296405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the transurethral ethanol ablation of the prostate (TEAP) for symptomatic benign prostatic hyperplasia (BPH): a European multi-center evaluation.
    Grise P; Plante M; Palmer J; Martinez-Sagarra J; Hernandez C; Schettini M; Gonzalez-Martin M; Castiñeiras J; Ballanger P; Teillac P; Rolo F; Baena V; Erdmann J; Mirone V
    Eur Urol; 2004 Oct; 46(4):496-501; discussion 501-2. PubMed ID: 15363567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open study on the efficacy and safety of transurethral needle ablation of the prostate in treating symptomatic benign prostatic hyperplasia: the University of Florida experience.
    Kahn SA; Alphonse P; Tewari A; Narayan P
    J Urol; 1998 Nov; 160(5):1695-700. PubMed ID: 9783934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
    Rosario DJ; Phillips JT; Chapple CR
    J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia.
    Bruskewitz R; Issa MM; Roehrborn CG; Naslund MJ; Perez-Marrero R; Shumaker BP; Oesterling JE
    J Urol; 1998 May; 159(5):1588-93; discussion 1593-4. PubMed ID: 9554360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: The CLasP study.
    Gujral S; Abrams P; Donovan JL; Neal DE; Brookes ST; Chacko KN; Wright MJ; Timoney AG; Peters TJ
    J Urol; 2000 Jul; 164(1):59-64. PubMed ID: 10840425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of transperineal prostatic block for transurethral needle ablation for benign prostatic hyperplasia: the Emory University Experience.
    Issa MM; Perez-Brayfield M; Petros JA; Anastasia K; Labadia AJ; Miller LE
    J Urol; 1999 Nov; 162(5):1636-9. PubMed ID: 10524886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transurethral needle ablation of the prostate: report of initial United States clinical trial.
    Issa MM
    J Urol; 1996 Aug; 156(2 Pt 1):413-9. PubMed ID: 8683692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of transurethral needle ablation and resection of the prostate on pressure flow urodynamic parameters: analysis of the United States randomized study.
    Roehrborn CG; Burkhard FC; Bruskewitz RC; Issa MM; Perez-Marrero R; Naslund MJ; Shumaker BP
    J Urol; 1999 Jul; 162(1):92-7. PubMed ID: 10379748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
    Roehrborn CG; McVary KT; Elion-Mboussa A; Viktrup L
    J Urol; 2008 Oct; 180(4):1228-34. PubMed ID: 18722631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transurethral ethanol injection therapy of benign prostatic hyperplasia: four-year follow-up.
    Sakr M; Eid A; Shoukry M; Fayed A
    Int J Urol; 2009 Feb; 16(2):196-201. PubMed ID: 19054163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transurethral ethanol injection for prostatic obstruction: an excellent treatment strategy for persistent urinary retention.
    Mutaguchi K; Matsubara A; Kajiwara M; Hanada M; Mizoguchi H; Ohara S; Yasumoto H; Usui T
    Urology; 2006 Aug; 68(2):307-11. PubMed ID: 16904442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemo-ablation of the prostate with dehydrated alcohol for the treatment of prostatic obstruction.
    Ditrolio J; Patel P; Watson RA; Irwin RJ
    J Urol; 2002 May; 167(5):2100-3; discussion 2103-4. PubMed ID: 11956449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study.
    Roehrborn CG; Siami P; Barkin J; Damião R; Major-Walker K; Morrill B; Montorsi F;
    J Urol; 2008 Feb; 179(2):616-21; discussion 621. PubMed ID: 18082216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethanol injection therapy of the prostate for benign prostatic hyperplasia: preliminary report on application of a new technique.
    Goya N; Ishikawa N; Ito F; Ryoji O; Tokumoto T; Toma H; Yamaguchi Y
    J Urol; 1999 Aug; 162(2):383-6. PubMed ID: 10411043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transurethral ethanol injection therapy for prostatic hyperplasia: 3-year results.
    Goya N; Ishikawa N; Ito F; Kobayashi C; Tomizawa Y; Toma H
    J Urol; 2004 Sep; 172(3):1017-20. PubMed ID: 15311027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel transurethral microwave thermal ablation system to treat benign prostatic hyperplasia: results of a prospective multicenter clinical trial.
    Ramsey EW; Miller PD; Parsons K
    J Urol; 1997 Jul; 158(1):112-8; discussion 118-9. PubMed ID: 9186335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transurethral prostatic tissue ablation via a single needle delivery system: initial experience with radio-frequency energy and ethanol.
    Plante MK; Bunnell ML; Trotter SJ; Jackson TL; Esenler AC; Zvara P
    Prostate Cancer Prostatic Dis; 2002; 5(3):183-8. PubMed ID: 12496979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostatic tissue ablation by injection: a literature review.
    Plante MK; Folsom JB; Zvara P
    J Urol; 2004 Jul; 172(1):20-6. PubMed ID: 15201730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).
    Woo HH; Chin PT; McNicholas TA; Gill HS; Plante MK; Bruskewitz RC; Roehrborn CG
    BJU Int; 2011 Jul; 108(1):82-8. PubMed ID: 21554526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.